![Monil Shah](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Monil Shah
Corporate Officer/Principal at
IMUGENE LIMITED
Net worth: 14 751 $ as of 30/05/2026
Profile
Monil Shah was the founder of Ventrus Biosciences, Inc. (founded in 2011) where he held the title of Vice President-Clinical Research & Development from 2011 to 2014.
He is currently the Chief Business Officer at Imugene Ltd. (since 2021) and the Chief Development Officer at WindMIL Therapeutics, Inc. He previously served as the Chief Operating Officer at IRX Therapeutics, Inc. and Eterna Therapeutics LLC (from 2017 to 2018).
Dr. Shah also held the position of VP-Operations & Clinical Development at LTR Pharma Ltd. Dr. Shah obtained undergraduate and doctorate degrees from Rutgers State University of New Jersey.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
IMUGENE LTD 0.04% | 29/06/2025 | 178,279 ( 0.04% ) | 14 751 $ | 30/05/2026 |
Monil Shah active positions
| Companies | Position | Start |
|---|---|---|
| IMUGENE LIMITED | Corporate Officer/Principal | 09/06/2021 |
WindMIL Therapeutics, Inc.
 WindMIL Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops and offers immunotherapies to treat cancer patients | Corporate Officer/Principal | - |
Former positions of Monil Shah
| Companies | Position | End |
|---|---|---|
Eterna Therapeutics LLC
 Eterna Therapeutics LLC Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops cytokine-based drugs for the treatment of cancer | Chief Operating Officer | 30/09/2018 |
Ventrus Biosciences, Inc.
 Ventrus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets phamaceutical products | Founder | 28/02/2014 |
IRX Therapeutics, Inc.
 IRX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Chief Operating Officer | - |
| LTR PHARMA LIMITED | Corporate Officer/Principal | - |
Training of Monil Shah
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
13
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
IRX Therapeutics, Inc.
IRX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Health Technology |
Ventrus Biosciences, Inc.
Ventrus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets phamaceutical products | Health Technology |
Imugene Ltd.
 Imugene Ltd. BiotechnologyHealth Technology Operates as a a clinical stage immuno-oncology company | Health Technology |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
WindMIL Therapeutics, Inc.
WindMIL Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops and offers immunotherapies to treat cancer patients | Health Technology |
Eterna Therapeutics LLC
Eterna Therapeutics LLC Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops cytokine-based drugs for the treatment of cancer | Health Technology |
Ltr Pharma Ltd.
 Ltr Pharma Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
- Stock Market
- Insiders
- Monil Shah
